Infliximab-related lupus and associated valvulitis: A case report and review of the literature

Arthritis Care and Research

Volumn 55, Issue 1, 2006, Pages 163-166

  Chadha, Tina ^a,b   Hernandez, Jesus Edward ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b BCM 285 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; INFLIXIMAB; METHYLPREDNISOLONE;

ADULT; ANEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; ENDOCARDITIS; FEMALE; HUMAN; HYPOCOMPLEMENTEMIA; LEUKOPENIA; MITRAL VALVE DISEASE; RASH; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HEART VALVE DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE;

EID: 32544431935     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.21702     Document Type: Article

References (14)

1. Charles PJ, Smeenk RJ, de Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor α: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum 2000;43:2383-90.
2. Eriksson C, Engstrand S, Sundqvist KG, Rantapaa-Dahlqvist S. Autoantibody formation in patients with rheumatoid arthritis treated with anti-TNF alpha. Ann Rheum Dis 2005;64:403-7.
3. Klapman JB, Ene-Stroescu D, Becker MA, Hanauer SB. A lupus-like syndrome associated with infliximab therapy. Inflamm Bowel Dis 2003;9:176-8.
4. Debandt M, Vittecoq O, Descamps V, le Loet X, Meyer O. Anti-TNF-alpha-induced systemic lupus syndrome. Clin Rheumatol 2003;22:56-61.
5. Cairns AP, Duncan MK, Hinder AE, Taggart AJ. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis [letter]. Ann Rheum Dis 2002; 61:1031-2.
6. Favalli E, Sinigaglia L, Varenna M, Arnoldi C. Drug-induced lupus following treatment with infliximab in rheumatoid arthritis. Lupus 2002;11:753-5.
7. Shakoor N, Michalska M, Harris CA, Block JA. Drug-induced systemic lupus erythematosus associated with etanercept therapy [letter]: Lancet 2002;359:579-80.
8. Mohan AK, Edwards ET, Cote TR, Siegel JN, Braun MM. Drug-induced systemic lupus erythematosus and TNF-alpha blockers. Lancet 2002;360:646.
9. Fluture A, Chaudhari S, Frishman WH. Valvular heart disease and systemic lupus erythematosus: therapeutic implications. Heart Dis 2003;5:349-53.
10. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-63.
11. Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum 1997;27:27-35.
12. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424-30.
13. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975;58: 243-64.
14. Schur PH, Rose BD. Drug-induced lupus. URL: www.utdol.com/application/ topic.asp?file=glomrdis/6022&type=A&selectedTitle =1~14.